These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17524926)

  • 1. Does donor's fatty liver change impact on early mortality and outcome of liver transplantation.
    Nikeghbalian S; Nejatollahi SM; Salahi H; Bahador A; Sabet B; Jalaeian H; Geramizadeh B; Dehghani SM; Malek-Hosseini SA
    Transplant Proc; 2007 May; 39(4):1181-3. PubMed ID: 17524926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
    Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
    Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of steatotic graft in living-donor liver transplantation.
    Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
    Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of graft steatosis on liver function and organ survival after liver transplantation.
    Angele MK; Rentsch M; Hartl WH; Wittmann B; Graeb C; Jauch KW; Loehe F
    Am J Surg; 2008 Feb; 195(2):214-20. PubMed ID: 18154767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding postmortem donor pool using steatotic liver grafts: a new look.
    Noujaim HM; de Ville de Goyet J; Montero EF; Ribeiro CM; Capellozzi VL; Crescentini F; Casagrande M; Santos RG; Curvello L; de Miranda MP; Genzini T
    Transplantation; 2009 Mar; 87(6):919-25. PubMed ID: 19300197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvesicular liver graft steatosis as a risk factor of initial poor function in relation to suboptimal donor parameters.
    Cieślak B; Lewandowski Z; Urban M; Ziarkiewicz-Wróblewska B; Krawczyk M
    Transplant Proc; 2009 Oct; 41(8):2985-8. PubMed ID: 19857657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27.
    Avolio AW; Frongillo F; Nicolotti N; Mulè A; Vennarecci G; De Simone P; Agnes S
    Transplant Proc; 2009; 41(1):208-12. PubMed ID: 19249515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of degree of hepatic steatosis on graft function and postoperative complications of liver transplantation.
    Perez-Daga JA; Santoyo J; Suárez MA; Fernández-Aguilar JA; Ramírez C; Rodríguez-Cañete A; Aranda JM; Sánchez-Pérez B; Montiel C; Palomo D; Ruiz M; Mate A
    Transplant Proc; 2006 Oct; 38(8):2468-70. PubMed ID: 17097969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. True impact of the indication of cirrhosis and the MELD on the results of liver transplantation.
    Santoyo J; Suarez MA; Fernandez-Aguilar JL; Perez Daga JA; Sanchez-Perez B; Ramirez C; Aranda JM; Rodríguez-Canete A; Gonzalez-Sanchez A
    Transplant Proc; 2006 Oct; 38(8):2462-4. PubMed ID: 17097967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired.
    Cho JY; Suh KS; Kwon CH; Yi NJ; Lee KU
    Surgery; 2006 Apr; 139(4):508-15. PubMed ID: 16627060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function.
    Cywinski JB; Mascha E; Miller C; Eghtesad B; Nakagawa S; Vincent JP; Pesa N; Na J; Fung JJ; Parker BM
    Liver Transpl; 2008 Jan; 14(1):59-65. PubMed ID: 18161840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marginal grafts: finding the correct treatment for fatty livers.
    Salizzoni M; Franchello A; Zamboni F; Ricchiuti A; Cocchis D; Fop F; Brunati A; Cerutti E
    Transpl Int; 2003 Jul; 16(7):486-93. PubMed ID: 12669196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of graft steatosis after liver transplantation: prospective study.
    Li J; Liu B; Yan LN; Zuo YX; Li B; Zeng Y; Zhang SF; Li FG
    Transplant Proc; 2009 Nov; 41(9):3560-3. PubMed ID: 19917344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suspect the donor with potential infection in the adult deceased donor liver transplantation.
    Wu TJ; Lee CF; Chou HS; Yu MC; Lee WC
    Transplant Proc; 2008 Oct; 40(8):2486-8. PubMed ID: 18929774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of donor body mass index on primary graft nonfunction, retransplantation rate, and early graft and patient survival after liver transplantation.
    Yoo HY; Molmenti E; Thuluvath PJ
    Liver Transpl; 2003 Jan; 9(1):72-8. PubMed ID: 12514776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomes.
    Smith JO; Shiffman ML; Behnke M; Stravitz RT; Luketic VA; Sanyal AJ; Heuman DM; Fisher RA; Cotterell AH; Maluf DG; Posner MP; Sterling RK
    Liver Transpl; 2009 Mar; 15(3):273-9. PubMed ID: 19243008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.